MILNER: EVENTS CALENDAR

This event will review some areas in which clinical genomics can have a significant impact including rare diseases, infection diseases and cancer and will discuss how to ensure these technologies reach the widest patient audience possible. It is aimed at anybody from academia or industry with an interest in genomics and its impact on healthcare […]

The meeting will bring together world class speakers and leading academic and industry experts who will discuss the challenges and opportunities in the area of new technologies and novel targets to improve the success of drug discovery and to develop new therapeutic agents. Hear up-to-date views on this exciting and rapidly evolving area, including presentations […]

The theme for BioTrinity 2018 is 'Next Generation Healthcare' which will be explored via a range of insightful keynote and panel discussions.

The conference provides new, experienced and potential users of Linguamatics I2E software an excellent opportunity to explore the latest trends in natural language processing-based text mining.

This meeting will highlight a range of perspectives and contributions to the development of new therapeutics. Cambridge New Therapeutics Forum events are open to all scientists researching new therapeutics in Cambridge and the local area.

Metrion Biosciences and AstraZeneca will be co-hosting the fifth Cambridge Ion Channel Forum. Professor Peter McNaughton (King’s College London) will be giving the keynote presentation about his research into the role of HCN2 ion channels in pain.

This BioWednesday will explore how drugs can be repurposed, with examples from those working in this area. It will also focus on challenges faced with obtaining patents for repurposed drugs and strategies to overcome these hurdles.

The aim of this series is to provide a forum for expert reviews and discussion on 'hot topics' and current techniques in Biology. The series is now organised by Postdocs in Biology throughout Cambridge and open to all researchers from the Departments of Biological Sciences.

This event will help to identify key technological and scientific investment areas and offers a unique networking, partnering and business development opportunity.

CUTEC (Cambridge University Technology & Enterprise Club) has brought together a range of high profile speakers from big tech companies to biotech start-ups, to discuss the future of biotech in healthcare.

ON Helix is One Nucleus' annual translational research conference for the Life Sciences industry. The two-day event aims at informing delegates of how to turn early stage inventions and ideas into innovative health treatments (new medicines, novel biomarkers, useful medical devices or improved medical practices).

The Milner Therapeutics Symposium This Symposium is an opportunity for scientists from academia and industry to discuss the latest academic and clinical research and how it could be applied in the pharma and biotech industry to develop new treatments. It is our key networking event for Milner Therapeutics Institute alliance partners. Non-Affiliated Companies If you […]

Understand the structure of the pharma business development process – Grasp the terminology, challenges, concepts & tools in each step, from analysis and planning, to closing and following-up a deal – be prepared for the financial and legal pitfalls.

This meeting will focus on the application of genome engineering to identify novel drug targets through large scale CRISPR based functional genomics studies, target validation in developing advanced cellular and in vivo disease models, and the pioneering applications in therapeutic genome editing.

This meeting will be hosted by Cambridge Enterprise at the Hauser Forum on the West Cambridge site. For this meeting Professor Peter McNaughton, now at King’s College London, will update us on his research into neuropathic pain, and Professor Jim Huntington from the Cambridge Institute for Medical Research, will share some of his work and […]

ELRIG Drug Discovery 2019: Looking back to the Future 5th & 6th November, Liverpool, UK This year will include plenary introductions assessing progress so far, and setting the challenges for discovering the drugs of the future. These will be followed by cutting edge talks and examples of new directions in drug discovery.

The Cambridge Alliance on Medicines Safety (CAMS) is delighted to welcome Dr Chris Powell from GSK to talk about the important issue of safety studies needed to support clinical trials.

A Korean delegation of pharma, SMEs, and investment companies (including Chong Kun Dang Pharmaceuticals, SK Chemicals, Yuhan Corporation, Daewoong Pharmaceuticals Co Ltd, ShinPoong Pharm Co Ltd, Korea Investment Partners and SBI Investment) are visiting Cambridge in the hope of meeting UK biotech and pharma companies. Their aim is to identify opportunities for collaboration, investment or […]

A summit to explore the UK advantage in Cell and Gene Therapy How can joining up science and value in cell and gene therapy deliver global health impact?  The summit will explore the journey from science to patients and what value means for different people and organisations. This half day event is for scientists, investors […]

An event (with free registration) to foster the In silico Toxicology Community in the UK and beyond. Scientific contributions are as welcome as those on ongoing work, regulatory aspects, industry perspectives, databases, relevant software, journals etc. in the field.